http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013526590-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013526590-A |
| titleOfInvention | Fused ring quinazoline derivatives and uses thereof |
| abstract | The present invention discloses a kind of fused quinazoline derivative and use thereof, and the fused quinazoline derivative according to the present invention is a protein tyrosine kinase inhibitor and an aurora kinase inhibitor. The protein tyrosine kinase inhibitor and the aurora kinase inhibitor are useful for the treatment of cancer, leukemia and diseases relating to differentiation and proliferation. The protein tyrosine kinase and aurora kinase dual inhibitor is a compound having the following structural formula or a salt thereof. [Selection figure] None [Chemical formula 5] |
| priorityDate | 2010-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 421.